References
- Bock K. W., Kahl R., Lilienblum W. Induction of rat hepatic UDP-glucuronosyl-transferases by dietary ethoxyquin. Naunyn-Schmiedeberg's Archives of Pharmacology 1980; 310: 249–252
- Corey E. J., Venkateswarlu A. Protection of hydroxyl groups as tert-butyldimethylsilyl derivatives. Journal of the American Chemical Society 1972; 94: 6190–6191
- Derbel M., Igarashi T., Satoh T. Differential induction of glutathione S-transferase subunits by phenobarbital, 3-methylcholanthrene and ethoxyquin in rat liver and kidney. Biochemica et Biophysica Acta 1993; 1158: 175–180
- Hinson J. A., Monks T. J., Hong R. J., Pohl L. R. 3-(Glutathion-S-yl) acetaminophen. A biliary metabolite of acetaminophen. Drug Metabolism and Disposition 1982; 10: 47–50
- Hjelle J. J., Klaassen C. D. Glucuronidation and biliary excretion of acetaminophen in rats. Journal of Pharmacology and Experimental Therapeutics 1984; 228: 407–413
- Ioannou Y. M., Burka L. T., Sanders J. M., Moorman M. P., Matthews H. B. Absorption, distribution, metabolism, and excretion of 1,2-dihydro-2,2,4-trimethylquinoline in the male F344 rat. Drug Metabolism and Disposition 1987; 15: 367–373
- Kahl R. Elevation of hepatic epoxide hydratase activity by ethoxyquin is due to increased synthesis of the enzyme. Biochemical and Biophysical Research Communications 1980; 95: 163–169
- Kahl R., Netter K. J. Ethoxyquin as an inducer and inhibitor of phenobarbital-type cytochrome P-450 in rat liver microsomes. Toxicology and Applied Pharmacology 1977; 40: 473–483
- Kim H. L., Ray A. C., Calhoun M. C. Ovine urinary metabolites of ethoxyquin. Journal of Toxicology and Environmental Health 1992; 37: 341–347
- Liu L., Klaassen C. D. Species differences in the mechanism of saturation of sulfate conjugation. Toxicologist 1993; 13: 329
- Monks T. J., Lau S. S. Reactive intermediates and their toxicological significance. Toxicology 1988; 52: 1–53
- Office of the Federal Register (OFR). National Archives and Records Administration. Code of Federal Regulations, Title 21. Food and Drugs. Part 172.140, 573.380, 573.400. US Government Printing Office, Washington 1990a
- Parke D. V., Rahim A., Walker R. Effects of ethoxyquin on hepatic microsomal enzymes. Biochemical Journal 1972; 130: 84P
- Sanders J. M., Matthews H. B., Burka L. T. Comparative metabolism and disposition of ethoxyquin in the rat and mouse. I. Disposition. Xenobiotica 1996; 26: 583–595
- Skaare J. U. Studies on the biliary excretion and metabolites of the antioxidant ethoxyquin, 6-ethoxy-2,2,4-trimethyl-1,2-dihydroquinoline in the rat. Xenobiotica 1979; 9: 659–668
- Skaare J. U., Solheim E. Studies on the metabolism of the antioxidant ethoxyquin, 6-ethoxy-2,2,4-trimethyl-1,2-dihydroquinoline in the rat. Xenobiotica 1979; 9: 649–657
- Surh Y., Kwon H., Tannenbaum S. R. Sulfotransferase-mediated activation of 4-hydroxy- and 3,4-dihydroxy-4-dihydrocyclopenta[c,d]pyrene, major metabolites of cyclopenta [c,d]pyrene. Cancer Research 1993; 53: 1017–1022
- Ter Muelen U., Ende M., Hunneman D. H., Remberg G., Walker R. Metabolic studies on the antioxidant ethoxyquin. Zeitschrift fuer Tierphysiologie, Tierernährung und Futtermittelkunde 1980; 43: 161–168
- Taimr L., Prusíková M., Pospísil J. Antioxidants and stabilizers. CXIII. Oxidation products of the antidegradant ethoxyquin. Angewandte Makromolekulore Chemie 1991; 190: 53–65
- Thorisson S., Gunstone F. D., Hardy R. Some oxidation products of ethoxyquin including those found in autoxidising systems. Chemistry and Physics of Lipids 1992; 60: 263–271
- Vermeulen N. P. E., Bessems J. G. M., Van De Straat R. Molecular aspects of paraacetamol-induced hepatotoxicity and its mechanism-based prevention. Drug Metabolism Reviews 1992; 24: 367–407